Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

7 Dec 2018 07:00

RNS Number : 7438J
S & U PLC
07 December 2018
 

7 December 2018

 

S&U plc

("S&U" or "the Group")

 

TRADING STATEMENT

 

S&U plc, the specialist motor finance and bridging lender, announces its trading update for the period from 1st August to 6th December 2018. Irrespective of recent economic and political uncertainty, S&U is pleased to confirm that current trading indicates full year results broadly in line with expectations.

 

Motor Finance

Although recent months have seen a slowdown in the motor industry compared to the highs of recent years, the impact on the used car finance market in which S&U operates has been less marked. Nevertheless, a combination of the slight reduction in the record level of loan applications seen in July, Advantage's prudently tightened under-writing and some recent increase in competitive pressure, has seen new loan agreements in the year to date at 18,710. Whilst 7% less than last year, these are still the second highest volumes in Advantage's history by a comfortable margin.

 

Both Advantage's customer base and current net receivables continue to grow and, while at a slower rate than previously anticipated, they are both at record levels. The former now stands at 59,000 and the latter at £267m. The quality of this book remains high, as evidenced by the year to date risk adjusted yield against average monthly receivables of 25.0% against 25.4% in July. Year to date monthly collections are 18% up on last year at just under £115m and are beginning to evidence the improvement in new customer quality on which our under-writing policy is focussed. All this is consistent with maintaining Advantage's return on capital employed before cost of funds at around its current level of 15.0% (July 18: 15.4%).

 

As a result, Advantage remains well placed to take advantage of an upturn in the motor finance market when consumer confidence improves.

 

Property Bridging Finance

As we announced recently, Aspen Bridging has made good progress and has now moved out of its pilot stage. Its loan book has now reached £18m of net receivables (2017: £9m).

 

In a competitive market it continues to maintain margins and refine its flexible and bespoke bridging products. In particular, its stepped products have proved both popular and profitable and this has been reflected in Aspen's good repayments profile.

 

We anticipate increasing our total investment in Aspen to c.£30m in 2019 and further funding will be dependent on Aspen's requirements and performance.

 

Funding

Since the recent economic climate and trends within the business have seen the Group become more cash generative, S&U's current committed facilities of £135m provide ample and sensible headroom for the business's anticipated growth. Further facilities will be put in place as required.

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

 

"At a time of considerable political and economic uncertainty in the UK, I am pleased to say that S&U retains a very strong financial base, growing expertise and experience and a prudent business philosophy which will enable us to make the most of the opportunities presented by the motor and property markets as 2019 unfolds."

 

"In a fast changing world these enormous strengths underpin our ability to continue to provide steady, sustainable growth for our shareholders."

 

 

For further information, please contact:

 

S&U

Anthony Coombs, Chairman 0121 705 7777

 

Newgate Communications

Bob Huxford, Imogen Humphreys 020 7653 9848

 

Peel Hunt

Adrian Trimmings, Rishi Shah 020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBIBDDUBGBGIL
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.